Category: Accesswire

  • Cubic Secure Communications to Showcase Cubic(R) Vector(TM) Multi-Orbit Hybrid SATCOM Antenna at Satellite 2026

    March 17, 2025 – Article was updated to make a wording correction in the body of the text

    Enabling resilient, assured connectivity across SATCOM networks in contested electromagnetic spectrum environments

    SAN DIEGO, CA / ACCESS Newswire / March 17, 2026 / Cubic Secure Communications, a business unit of Cubic Defense, will showcase its Vector multi-band, multi-beam, multi-orbit SATCOM antenna at Satellite 2026 (SatShow) from March 24-26 at the Walter E. Washington Convention Center in Washington, D.C.

    “As global operations become more complex, resilient connectivity is critical,” said Dan Moran, Vice President and General Manager of Secure Communications, Cubic Defense. “Vector redefines how warfighters connect across domains and constellations enabling multi-domain operations and critical missions by delivering multi-orbit, multi-beam capability from a single, software-defined antenna, providing continuous connectivity, even in contested environments.”

    Vector delivers resilient, assured communications across satellite networks. Engineered for air, ground and surface platforms, Vector enables simultaneous connectivity across low Earth orbit (LEO), medium Earth orbit (MEO), and geostationary Earth orbit (GEO) constellations in both Ku and Ka bands, helping resolve critical gaps in wideband tactical communications.

    Vector is a modular, low-size, weight and power (SWaP) optimized phased array antenna built on a software-defined, digitally beamformed architecture. Designed to support hybrid SATCOM and line-of-sight networks and expanded muti-function capabilities, Vector consolidates multiple apertures and functions into a single extensible system, providing a trade space between reduced SWaP-C and operational performance.

    The solution supports:

    • Multi-orbit, multi-band, multi-beam connectivity

    • Always-on communications with network redundancy

    • Interference detection and mitigation

    • Spectrum awareness and signal geolocation for network assurance

    • Open standards integration for future growth

    Cubic’s Secure Communications portfolio includes digital beamforming, open architecture interfaces to modems, and protected waveforms to deliver assured and stealthy communications for operations in contested and denied spectrum environments.

    Visit Cubic booth 2416 to speak with experts who will demonstrate Vector in action.

    To learn more about Cubic’s resilient SATCOM and secure communications solutions, visit https://www.cubic.com/defense/secure-communications.

    About Cubic
    Cubic creates and delivers technology solutions in transportation that make people’s lives easier by simplifying their daily journeys, and defense capabilities that help promote mission success and safety for those who serve their nation. Led by our talented teams around the world, Cubic is driven to solve global challenges through innovation and service to our customers and partners.

    Part of Cubic’s portfolio of businesses, Cubic Defense provides networked Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) products and services and is a leading provider of live, virtual, constructive, and game-based training solutions for both U.S. and Allied Forces. These mission-inspired capabilities enable assured multi-domain access; converged digital intelligence; and superior readiness for defense, intelligence, security, and commercial missions. For more information, visit: www.cubic.com.

    Media Contact:
    Geri MacDonald
    Cubic Defense
    geri.macdonald@cubic.com

    Touchdown PR for Cubic Defense
    Cubicdefense@touchdownpr.com

    SOURCE: Cubic Defense

    View the original press release on ACCESS Newswire

  • Red Wing Brings 120 Years Of Industry-Defining Craft To Work Apparel For The First Time

    Engineered with the same comfort, durability, and style that define Red Wing boots

    RED WING, MN / ACCESS Newswire / March 17, 2026 / Red Wing, the global benchmark for purpose-built footwear since 1905, announced today its entry into the Work Apparel category. For 120 years, Red Wing has built the boots that built America; now, that same industry-defining craft, quality, and industrial know-how shape a core collection of durable apparel essentials designed for comfort and style, both on and off the job.

    This introduction marks the brand’s first expansion into a dedicated Work Apparel vertical – a category distinct from, yet inspired by, Red Wing’s safety-rated personal protective equipment (PPE) that businesses and their workers have relied on for decades. Designed specifically for skilled trades and blue-collar professionals, this initial collection of hoodies, long-sleeve shirts, and pocket and graphic t-shirts is engineered to address the demands of the jobsite while remaining comfortable all day long.

    “We’ve spent 120 years perfecting the foundation of the worker’s uniform,” said Mike VanGoethem, Chief Product & Services Officer at Red Wing Shoe Company. “With our new Work Apparel, we aren’t just expanding a catalog; we’re honoring a standard. Our Internal compass has always been simple: if you are going to do something, do it right, no matter what. We’ve applied that exact same obsession with quality to every stitch of this clothing, ensuring it works as hard as the boots that carry our name.”

    Trades-Centered Fit Based on Worker Data & Feedback

    The new apparel line represents a scientific approach to garment fit – designed specifically around the movements and physical demands of the wearer. Red Wing collaborated with thousands of skilled tradespeople to map their real-world movement through 3D scanning, creating a data set that served as the foundation for the new designs.

    “By pairing this body-mapping data with detailed feedback about the pain points blue-collar workers experience in the field, we’ve engineered a human-centered fit designed to eliminate daily distractions,” said VanGoethem. “This ‘Hardworking, Easy Wearing’ philosophy allows the apparel to transition seamlessly from the jobsite to after-hours, providing a classic fit that stays comfortable throughout the day.”

    Quality That Keeps Up

    Utilizing premium materials like combed, ring-spun cotton and reinforced cotton-wrapped polyester thread, this Work Apparel is built to be in it for the long haul. From signature “Red Wing Red” looper stitching to bootlace-pattern drawcords on the hoodies, every detail is a nod to the 120-year heritage of the brand. This expansion highlights Red Wing’s deepening commitment to the trades, offering the brand’s legendary quality from head to toe.

    The New Work Apparel Essentials Include:

    • Hoodies: Constructed from 320 gsm cotton/poly fleece with a 3-piece hood and “bootlace” pattern drawcords.

    • Pocket Tees: Built with 200 gsm 100% cotton jersey featuring a rounded back tail for coverage while working.

    • Graphic Tees: Also built with 200 gsm 100% cotton jersey featuring the iconic “Wing” logo in “Red Wing Red” with a rounded back tail.

    Red Wing Work Apparel is now available online and in stores. For more information and to find a local Red Wing Store, please visit: redwing.com/apparel.

    About Red Wing

    Established in 1905, Red Wing is an American footwear brand built on a legacy of uncompromising craftsmanship and quality. From industry-leading boots to work apparel, Red Wing blends traditional construction with modern innovation to deliver products made to last and meet the demands of trades workers. Rooted in a simple but profound purpose – to help you build your life’s work – Red Wing designs gear with quality materials that support those who build our world with the confidence, style, and comfort they deserve.

    Media Contact:

    Name: Martina Corona
    Email: martina@notablypr.com

    SOURCE: Red Wing

    View the original press release on ACCESS Newswire

  • Introducing Proda, the Lifestyle Protein-Infused Soda Launching Exclusively at Sprouts Farmers Market

    Wellness Entrepreneur Matthew Postlethwaite Partners With Suja Co-Founder to Bring to Market the First Protein-Infused Soda Built for Everyday Life

    LOS ANGELES, CA / ACCESS Newswire / March 17, 2026 / Proda debuts as an all-natural protein-infused soda that aims to push protein beyond the fitness niche and into the lives of everyday people.

    Co-founded by Matthew Postlethwaite, wellness entrepreneur and actor best known for his role in Peaky Blinders, and Jeff Church, co-founder and former CEO of Suja Juice, Proda is bringing protein to wider audiences – to be enjoyed as a daily ritual or a guilt-free soda swap during meals, and anything in between.

    “After witnessing the health journeys of my family and through my experience in working with a variety of protein brands, my intention behind building Proda centered on making protein more approachable to all ages,” says Matthew Postlethwaite, co-founder and co-CEO of Proda. “Leading with crisp and refreshing flavor, we made sure Proda delivers the purest, complete protein on the market. It took us nearly a year and a half, with over 1,000 hours, to perfect every detail and ensure craveable taste – because if it doesn’t taste amazing, none of the rest matters.”

    “Traditional protein beverages and emerging protein sodas brands have over-indexed on the fitness and muscle building space, and Proda wants to turn that paradigm on its head. We believe that tomorrow’s protein category won’t be built on more; rather, it will be built on the best,” says Jeff Church, co-founder and co-CEO of Proda. “Most consumers want to move towards being a little bit healthier, but they don’t want to be punished by a poor-tasting product or they just won’t repeat their purchase. We’ve spent tremendous time and effort to ensure Proda is best in class regarding taste and benefits.”

    Sprouts Farmers Market has signed on as Proda’s exclusive national launch partner, offering Sprouts customers first access in retail stores.”At Sprouts, innovation and health are at the heart of everything we do, and we’re always looking for partners who are redefining what better-for-you can mean,” says Kim Coffin, Chief Forager at Sprouts Farmers Market. “Proda is exactly the kind of bold, forward-thinking brand we’re excited to support – bringing together elevated nutrition, craveable flavor, and everyday functionality. We’re proud to help introduce emerging products like Proda to shoppers nationwide while continuing to lead the way in discovering what’s next in wellness.”

    Each 12 oz. can of Proda delivers clean ingredients including 10g of clear whey protein isolate, 3g of fiber, zero sugar, natural sweeteners, zero lactose, and is gluten- and caffeine-free, with approximately 45 calories.

    Proda’s flavor lineup includes seven nostalgic-meets-modern flavors: Classic Orange, Shirley Temple, Cherry Lime, Strawberry Lemonade, Lemon Lime, Golden Apple, and Root Beer.

    Proda will be available at Sprouts Farmers Market shelves nationwide on April 1, 2026, for $3.49 per can, as well as at DrinkProda.com, Amazon, and TikTok Shop.

    ABOUT Proda:

    Proda is a protein soda built for real life. Founded by Jeff Church, co-founder and former CEO of Suja Juice, and Matthew Postlethwaite, award-winning actor and wellness entrepreneur best known for his role in Peaky Blinders, Proda was designed for everyday life, not the supplement shelf. Each 12 oz. can delivers 10 grams of protein, 3 grams of fiber, and zero sugar across seven flavors: Lemon Lime, Classic Orange, Cherry Lime, Strawberry Lemonade, Golden Apple, Shirley Template, and Root Beer. Proda launches at Sprouts Farmers Market nationwide on April 1, 2026, and is available at drinkproda.com, Amazon, and TikTok Shop. Follow @drinkproda on Instagram and TikTok.

    About Sprouts Farmers Market:

    True to its farm-stand heritage, Sprouts offers a unique grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products paired with purpose-driven people. The healthy grocer continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based and gluten-free. Headquartered in Phoenix, and one of the largest and fastest growing specialty retailers of fresh, natural and organic food in the United States, Sprouts employs approximately 36,000 team members and operates more than 480 stores in 25 states nationwide. To learn more about Sprouts, and the good it brings communities, visit sprouts.com/about/.

    Media Contact:
    SEQUEL, Inc.
    proda@sequel-inc.com

    SOURCE: Proda

    View the original press release on ACCESS Newswire

  • Sauce Labs CEO, Prince Kohli, Says $1 Trillion Software Quality Industry Has Been “Building Wrong” for 20 Years

    The new Sauce AI for Test Authoring launch targets the most labor-intensive slice of the 22% of IT budgets spent on quality assurance, by shifting engineering teams from writing test cases to specifying business intent that the platform autonomously turns into self-improving test suites.

    SAN FRANCISCO, CA / ACCESS Newswire / March 17, 2026 / Sauce Labs Inc., the world’s largest full-lifecycle, test automation platform, today announced the general availability of Sauce AI for Test Authoring, an AI Agent that translates business intent into framework-agnostic executable test suites that can be run instantly on Sauce Labs’ virtual and real-device clouds.

    This launch introduces a new paradigm for DevOps: Intent-Driven Testing, designed to bridge the “Velocity and Quality Gap”, the widening distance between how fast AI generates code and how slowly teams can validate it for enterprise-grade quality.

    High-quality test creation is one of software development’s most persistent bottlenecks. Developers spend 30%+ of their time writing and maintaining test suites, while non-technical team members, business analysts, product managers, and manual QA testers with deep domain knowledge remain locked out of automation entirely due to the coding expertise required.

    Disrupting the $1 Trillion Quality Assurance & Engineering Spend
    Today, Fortune 2000 companies dedicate 22% to 25% of their total IT budgets to Quality Assurance & Engineering, representing over $1 trillion in aggregate annual spend across global enterprise IT. As these enterprises adopt GenAI to ship code at up to 10x their historical velocity, they face several key challenges:

    • Test Authoring Speed and Ensuring Quality: 89% of CIOs report that “Test Authoring Speed” is now the primary hurdle to AI-driven delivery

    • The Coverage Deficit: Automated test coverage for complex journeys typically plateaus at under 35%

    • The Maintenance Trap: Teams spend 40% of their working hours fixing “flaky” tests or maintaining legacy scripts

    “AI can generate millions of lines of code in minutes,” said Dr. Prince Kohli, CEO of Sauce Labs. “The question for enterprises is: Can you verify it and trust it with your business? We are solving this problem, permanently.”

    Reinventing for the AI Era: Intent-Driven Testing
    Today, Sauce Labs is reinventing the future of test automation with Intent-Driven Testing that replaces brittle, hand-coded test scripts with autonomous, self-improving test suites and validation.

    Sauce AI for Test Authoring automatically understands intended application behavior by scanning the application workflow or interpreting specifications written by product managers or designs from tools such as Figma. In addition, it allows engineers, application developers and product managers to describe application behavior in natural language. The platform then autonomously generates complete, executable test suites for web, Android, and iOS, with the option to execute them in the Sauce Labs Test Cloud, and automatically reports the results, including insights on where to look and what to fix. Key capabilities include:

    • 90%+ Faster Automated Test Case Generation: Achieving real-time test creation from product specifications.

    • Resilient, Stable Test Scripts: Framework-agnostic tests built to adapt to application changes, with significantly fewer flaky failures and less maintenance overhead.

    • 99%+ Automatic Coverage: Eliminating “blind spots” in the user journey.

    • Built-in Review and Editing: Ensuring human oversight and control over AI-generated tests, allowing teams to validate, refine, and maintain reliability.

    • Autonomous Learning Loop: Continuous feedback that improves test accuracy.

    The Data Moat: Deep Domain-Specific Testing Expertise
    Sauce AI for Test Authoring surpasses general-purpose AI with a superior understanding of application workflow and user intent, generating stable OS-agnostic and device-agnostic tests. Fueled by the industry’s most robust proprietary dataset, 8.7 billion real-world test runs, this “Data Moat” enables 41% faster root-cause analysis than general-purpose LLMs. Trusted by 80% of the world’s top ten financial institutions, Sauce Labs offers enterprise-grade platform capabilities for complex software environments.

    “Setting up mobile testing is traditionally painful and can take days and weeks. Sauce AI for Test Authoring’s no-code capability gives our team something they simply weren’t able to do before. It turns a major bottleneck into an automated process that anyone can navigate,” said a Director of Engineering at a Fortune 500 pharmaceutical company participating in the Sauce AI for Test Authoring early access program.

    Availability
    Sauce AI for Test Authoring is available now for enterprise customers. To learn how to reclaim your IT budget and join the Intent-Driven Test era, visit https://saucelabs.com/solutions/ai

    About Sauce Labs
    Sauce Labs is the world’s largest full-lifecycle, test automation platform, and the company behind Selenium. Trusted by 80% of the world’s top ten largest financial institutions and over 300,000 enterprise users, Sauce Labs provides the only AI platform capable of turning business intent into autonomous testing and quality assurance. With a proprietary dataset of 8.7 billion test runs, Sauce Labs empowers the Fortune 2000 to bridge the gap between AI-driven code generation and enterprise-grade software quality. Learn more at saucelabs.com.

    Media Contact:
    Justin Mauldin
    Salient PR
    achievemore@salientpr.com
    737-234-0936

    SOURCE: Sauce Labs

    View the original press release on ACCESS Newswire

  • A First-of-Its-Kind Video Game Based on Muslim Scientific Artifacts, Launching on March 20, 2026

    Unity Productions Foundation Announces VANISHED: Puzzle Quest

    WASHINGTON, D.C. / ACCESS Newswire / March 17, 2026 / Unity Productions Foundation (UPF), the award-winning film production company, is expanding into interactive media with the upcoming release of VANISHED: Puzzle Quest, an immersive first-person puzzle adventure inspired by the scientific legacy of the Islamic Golden Age.

    Players journey across nine historic centers of learning – including Samarkand, Baghdad, Damascus, Cairo, and Timbuktu – where pioneering scholars advanced astronomy, optics, engineering, mathematics, and mechanics in ways that helped shape the modern world. Along the way, players uncover hidden clues, confront escalating challenges, and interpret medieval artifacts once used to map the stars, predict the seasons, and lay the groundwork for modern science.

    The game features meticulously modeled historical instruments – from astrolabes and celestial spheres to water clocks and mechanical devices – that are integral to gameplay. Mastering these tools is essential to solving puzzles, navigating hazards, and restoring knowledge before it disappears forever.

    VANISHED: Puzzle Quest launches worldwide on iOS, Android, Steam, and the Epic Games Store on March 20, coinciding with Eid al-Fitr, the celebration marking the end of Ramadan. The release is accompanied by a companion website at vanished.game, offering additional educational resources and behind-the-scenes content.

    The game was developed in partnership with Saltium Games, an international studio based in Munich and Bosnia. Its core team includes Muslim developers and creatives whose cultural insight helped shape the game’s historical authenticity, narrative voice, and visual design. The collaboration blends rigorous research with cinematic storytelling and engaging gameplay to create an experience that is highly entertaining.

    Alex Kronemer, Executive Producer at UPF, said, “We set out to build a game that is not only fun to play, but intellectually meaningful – an experience that lets players interact with the very tools that helped build modern science, crafted by a team that understands this heritage from within.”

    For press inquiries, screenshots, or trailer access, please contact:
    Aliyah VanPelt
    Outreach@upf.tv

    Press Kit available here.

    SOURCE: Unity Productions Foundation 501(c)(3)

    View the original press release on ACCESS Newswire

  • Voxelmaps Launches Real-Time City Digital Twin for San José, Powered by NVIDIA AI

    Voxelmaps and NVIDIA partner to give city teams real-time 3D visibility into streets, infrastructure, and urban change – with natural-language querying built in.

    SAN JOSE, CA / ACCESS Newswire / March 17, 2026 / Voxelmaps today announced the deployment of a real-time city digital twin for the City of San José, developed in collaboration with NVIDIA. The initiative combines continuous street-level LiDAR and imagery capture through the Voxelmaps Reality Capture Network with NVIDIA Jetson platform and NVIDIA accelerated computing to create a living digital model of the city that updates continuously as urban environments change.

    The data captured through the Reality Capture Network is processed through Voxelmaps City Insights, its 4D real-time city digital twin platform, enabling municipal teams to work from an always-current view of streets, infrastructure, and urban change over time.

    The deployment demonstrates how AI-powered digital twins can help cities better understand and manage complex urban environments. By combining continuous sensing, high-resolution spatial data, and accelerated AI computing, the platform creates a living model of the city that can support infrastructure monitoring, urban planning, and new forms of human-AI interaction with the built environment.

    “At city scale, the challenge is not creating a 3D model once – it’s keeping it live and current,” said Peter Atalla, CEO of Voxelmaps. “Voxelmaps Reality Capture Network, using our SYMBO Duo Realtime 3D Mapping Sensors, combined with NVIDIA Jetson at the edge and NVIDIA-accelerated computing across the workflow, enables a city digital twin that stays measurable, refreshable, and practical for day-to-day city operations.”

    Multimodal City Intelligence at Scale

    The digital twin is built from continuously captured street-level data collected through the Voxelmaps Reality Capture Network, which uses SYMBO Duo Realtime 3D Mapping Sensors to capture LiDAR and high-resolution imagery.

    Within Voxelmaps City Insights, this data is fused into a continuously updated urban model that combines:

    • LiDAR point clouds for precise geometry and measurement of infrastructure and urban assets

    • High-resolution imagery to enable feature detection and semantic understanding

    • 3D Gaussian Splatting (3DGS) workflows to generate photorealistic visualization of city environments

    Unlike traditional mesh-based modeling approaches, which are difficult to maintain at city scale, 3D Gaussian Splatting enables continuously refreshed visual representations that better support incremental updates as new data is captured.

    Natural-Language Interaction with City Data

    Voxelmaps has integrated NVIDIA Cosmos Reason 2, an open, customizable reasoning vision-language model (VLM), enabling natural-language interaction with visual and temporal city data within Voxelmaps City Insights.

    Authorized city users can query the digital twin using everyday language to support operational awareness, planning, and infrastructure management.

    Example queries include:

    • “Show me where roadworks have changed curb access since last month.”

    • “Identify corridors with low streetlighting coverage relative to comparable neighborhoods.”

    • “List blocks with repeated pavement defects and estimate the affected surface area.”

    Looking forward, Voxelmaps is working through integration with latest version of NVIDIA Metropolis Blueprint for video search and summarization (VSS) to enable the deployment of video analytics AI agents.

    Supporting City Operations and Planning

    Voxelmaps’ work with NVIDIA and the City of San José emphasizes measurable outputs, traceability to source data, and clear governance over how insights are generated and used.

    The platform is designed to support a range of municipal workflows, including:

    • Improved visibility into street-level conditions and urban change

    • Proactive infrastructure maintenance and asset monitoring

    • Broader access to spatial intelligence beyond specialist GIS teams

    • Data-driven planning and decision-making to improve residential services

    San José – home to many leading AI and technology companies – provides a real-world testbed for next-generation AI-powered city infrastructure and digital twin technologies.

    Scaling the Reality Capture Network

    Voxelmaps plans to expand the Voxelmaps Reality Capture Network, using its SYMBO Duo Realtime 3D Mapping Sensors, and deploy Voxelmaps City Insights across 100 U.S. cities over the next two years, supporting a new generation of real-time digital twins designed for urban operations.

    About Voxelmaps

    Voxelmaps digitalizes the physical world for Physical AI, enabling the creation of real-time, living models of cities and complex environments. Through the Voxelmaps Reality Capture Network and Voxelmaps City Insights, the company produces high-fidelity, time-aware (4D) digital representations that support continuous measurement, monitoring, and analysis of the physical world.

    Voxelmaps’ data and platforms help power Large World Models (LWMs) and the next generation of robots, autonomous systems, and AI technologies that need to perceive, navigate, and interact with real-world environments.

    Media Contact (Voxelmaps)

    Peter Atalla
    CEO, Voxelmaps
    +44 7970 717141
    peter@voxelmaps.com

    Forward-Looking Statements

    This press release contains forward-looking statements, including statements regarding planned deployments, anticipated capabilities, and potential impacts. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially.

    SOURCE: Voxelmaps Inc.

    View the original press release on ACCESS Newswire

  • High-Resolution Airborne Survey Completed at Music Valley HREE Project

    Mapping and sampling underway to refine geological model

    SAN BERNARDINO, CA / ACCESS Newswire / March 17, 2026 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) (Dateline or the Company) is pleased to announce the completion of the geophysical survey covering the Music Valley Heavy Rare Earth Project (Music Valley), located in Riverside and San Bernardino Counties, California, USA.

    The magnetic and radiometric survey included all of the 20,520 acres highlighted in the expanded Music Valley Project announcement (ASX Announcement 11 March 2026).

    The helicopter-borne survey was undertaken by Precision GeoSurveys based in Reno, Nevada. The 2,172 line kilometre survey was flown on 50m spaced lines at a height of 30m using state of the art equipment.

    Highlights

    • 2,172 line kilometre survey completed:The helicopter-borne magnetic and radiometric survey has been completed over the expanded Music Valley HREE Project area, ahead of schedule.

    • Low level = high resolution: The survey was completed on 50 metre line spacings at a flight height of 30 metres, which will generate a high-resolution dataset for processing and interpreting.

    • Data Analysis Underway: The survey data has been provided to Mitre Geophysics for processing, inversions and analysis.

    • Mapping and Sampling Underway: Dateline’s consulting REE and structural geology specialists are in the field, mapping and rock chip sampling across the expanded Music Valley HREE Project area.

    Dateline’s Managing Director, Stephen Baghdadi, commented:

    “Completion of the Music Valley airborne survey represents a step in Dateline’s systematic exploration of this emerging heavy rare earth district. The data will now be processed and integrated with field mapping and rock chip sampling to refine the Company’s geological model and guide the next phase of exploration.”

    https://storage.googleapis.com/accesswire/media/1148423/dateline-img1-03172026.png

    Figure 1: Music Valley HREE Project aerial geophysical survey area shown in red hatched area

    Mapping and Field Sampling

    The Company’s REE specialist, Tony Mariano Jr and Structural geologist Dr Russell Mason, have commenced field mapping and sampling at Music Valley. The primary target will be outcrops of Pinto Gneiss and contact zones with the surrounding rocks in the area.

    Rock chip samples collected during this program will be dispatched for assaying, with results expected in 5-7 weeks.

    https://storage.googleapis.com/accesswire/media/1148423/dateline-img2-03172026.jpg
    https://storage.googleapis.com/accesswire/media/1148423/dateline-img3-03172026.jpg
    https://storage.googleapis.com/accesswire/media/1148423/dateline-img4-03172026.jpg

    Figure 2: Field and Pinto Gneiss outcrop photos from Music Valley

    Additional Information

    The Company notes that 252 of the 969 claims referenced in this announcement are the subject of proceedings currently before the Federal Court of Australia (Victoria Registry). Dateline will update the market in accordance with its continuous disclosure obligations.

    This press release has been authorized for release by the Board of Dateline Resources Limited.

    For more information, please contact:

    Stephen Baghdadi
    Managing Director
    +61 2 9375 2353

    Andrew Rowell
    Corporate & Investor Relations Manager
    +61 400 466 226
    a.rowell@dtraux.com
    www.datelineresources.com.au

    Follow Dateline on socials:
    X – @Dateline_DTR
    Truth Social – @dateline_resources
    LinkedIn – dateline-resources
    YouTube – @dateline.resources

    About Dateline Resources Limited

    Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) is an Australian company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.

    The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.

    On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.

    The Colosseum is located less than 10km north of the Mountain Pass Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.

    Dateline owns 100% of the high-grade Argos Strontium Project, also located in San Bernadino County, California. Argos is reportedly the largest strontium deposit in the U.S. with previous celestite production grading 95%+ SrSO4.

    In March 2026, Dateline consolidated the Music Valley Heavy Rare Earth Project in Riverside and San Bernardino Counties, California. The region has known HREE mineralization from USGS rock chip sampling, however it has not been subjected to modern exploration techniques.

    Forward-Looking Statements

    This announcement may contain “forward-looking statements” concerning Dateline Resources that are subject to risks and uncertainties. Generally, the words “will”, “may”, “should”, “continue”, “believes”, “expects”, “intends”, “anticipates” or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Dateline Resources’ ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behavior of other market participants. Dateline Resources cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements. Dateline Resources assumes no obligation and does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

    Competent Person Statement

    Sample preparation and any exploration information in this announcement is based upon work reviewed by Mr. Greg Hall who is a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM). Mr. Hall has sufficient experience that is relevant to the style of mineralization and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves” (JORC Code). Mr. Hall is a Non-Executive Director of Dateline Resources Limited and consents to the inclusion in the report of the matters based on this information in the form and context in which it appears.

    Company Confirmations

    The Company confirms it is not aware of any new information or data that materially affects the information included in the announcements dated 23 October 2024 with regard to the Colosseum MRE and 23 May 2025 with regard to Colosseum Project Economics. Similarly, the Company confirms that all material assumptions and technical parameters underpinning the estimates and the forecast financial information referred to in those previous announcements continue to apply and have not materially changed.

    SOURCE: Dateline Resources Limited

    View the original press release on ACCESS Newswire

  • TRNR Exhibits at HFA 2026 with All Four Brands and Strong Leadership Presence

    TRNR Now Operates Four Premium Fitness Brands Following Acquisition of Ergatta, Leading to Increased Guidance of more than $30 Million in 2026 Pro Forma Revenue

    Wattbike CEO Stephen Loftus and Newly Acquired Ergatta CEO Tom Aulet Among Executives Representing TRNR’s Multi-Brand Portfolio at Largest Commercial Fitness Trade Show in the US

    HFA Show Draws More Than 10,000 Attendees from Over 80 Countries

    AUSTIN, TX / ACCESS Newswire / March 17, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), owner and operator of the Wattbike, CLMBR, FORME, and Ergatta fitness brands, today announced its attendance at the 2026 Health & Fitness Association Show (“HFA 2026”) at the San Diego Convention Center. The Company is attending with all four of its brands and its largest-ever senior leadership team at the event. Investors can read more about TRNR’s goals and presence at the show in today’s commentary on the TRNR IR site.

    Trent Ward, CEO of TRNR, said: “HFA is the most important commercial fitness event in the US, and TRNR’s presence this year reflects how significantly the company has grown. Last year, we had two brands at this show. A year later, and we have doubled that presence. The additions – Wattbike and Ergatta – have increased our commercial footprint by many multiples, and the respective CEOs are here driving those businesses further forward. The whole team is also evaluating other potential acquisition candidates as HFA has historically been a place where we encounter compelling businesses, and we expect that pattern to continue this year. The portfolio we have built is becoming one of the most meaningful platforms in fitness, and we expect to add additional brands to it in the near-term.”

    About HFA 2026

    The Health & Fitness Association Show is the premier annual gathering of the global commercial fitness industry. HFA 2026 runs March 16-18 at the San Diego Convention Center, with the trade show floor open March 17-18. The event draws more than 10,000 attendees from over 80 countries and more than 400 exhibiting companies – from early-stage innovators to the world’s largest fitness equipment suppliers. Attendees include health club owners, gym operators, hospitality procurement professionals, and international distributors.

    2026 Context

    With the completion of the Ergatta acquisition earlier this month, TRNR now operates four premium fitness brands and has confirmed 2026 pro forma revenue guidance of more than $30 million. For detailed information on TRNR’s strategy and financial outlook, investors are directed to TRNR’s investor presentation and FAQ on the Company’s investor website, as well as its required filings with the U.S. Securities and Exchange Commission (SEC).

    TRNR Investor Contact
    ir@interactivestrength.com
    interactivestrength.com

    * * *

    This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. These forward-looking statements include, but are not limited to, statements regarding 2026 revenue guidance, M&A activity, acquisition candidate evaluation, and commercial performance expectations. The reader is cautioned not to rely on these forward-looking statements. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. A further list and descriptions of risks, uncertainties and other factors can be found in TRNR’s filings with the Securities and Exchange Commission.

    SOURCE: Interactive Strength Inc.

    View the original press release on ACCESS Newswire

  • Aspire Biopharma’s Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

    ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire”), wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran John Choe as Western Sales Director. Choe joins the leadership team with a distinguished career of scaling consumer brands and leading high-performance teams across the retail and beverage sectors.

    Choe joins Buzz Bomb following a successful tenure as District Manager at Yerbaé (2016-2025), where he specialized in the natural energy drink category, achieving a 70% increase in overall sales within a highly competitive market. He accomplished this by spearheading the development of brand ambassador programs and innovative marketing tools tailored to both identified and untapped consumer segments. His strategic use of S.W.O.T. analysis and his ability to navigate complex DSD (Direct Store Delivery) and wholesale relationships with partners like WinCo, KeHE, and Kroger was instrumental to his success.

    “John’s deep expertise in the beverage and retail sectors, combined with a visionary approach to market analysis and consumer engagement, makes him an ideal leader to spearhead our sales strategy in the western United States,” stated Kraig Higginson, Interim CEO of Aspire Biopharma. “The ability to build productive relationships and a creative approach to reaching both identified and untapped consumer segments will be instrumental as the brand continues to scale.”

    Choe’s extensive background includes pivotal roles at global brands such as:

    Nike (1999-2005): Managed major accounts like Nordstrom and specialized in futures ordering across Northern and Southern California.

    Mars Candy (2005-2009): Led sales and merchandising efforts for massive retail outlets including Walmart, Target, and Safeway.

    Bosch (2009-2012): Spearheaded training and product education for retail giants Home Depot, Lowe’s, and Ace Hardware.

    With 11 years of dedicated supervisory experience, Choe is a specialist in hiring, mentoring, and coaching direct reports to peak performance. His leadership style emphasizes compliance, accountability, and the development of talent. Furthermore, his fluency in Korean, Chinese, and Japanese provides a unique edge in engaging with diverse markets.

    “I am thrilled to join BUZZ BOMB at such a pivotal moment in its growth trajectory,” said John Choe. “The energy category is evolving quickly, and I look forward to leveraging my experience in retail partnerships to expand our footprint and bring Buzz Bomb’s innovative products to a wider audience.”

    John Choe holds a Master of Business Administration from the University of Phoenix and a Bachelor of Science in Business Management from the University of Utah.

    BUZZ BOMB Caffeine Products

    To learn more about BUZZ BOMB, or purchase product online, please visit https://buzzbombcaffeine.com or follows us on social media here:

    Facebook

    Instagram

    TikTok

    About Aspire Biopharma Holdings, Inc.

    Aspire Biopharma delivers supplements to the body rapidly and precisely.

    For more information, please visit www.aspirebiolabs.com

    Aspire Biopharma Holdings, Inc.

    Contact

    PCG Advisory
    Kevin McGrath
    +1-646-418-7002
    kevin@pcgadvisory.com

    Safe Harbor Statement

    This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the “safe harbor” provisions created by those laws. Aspire’s forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding our future operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements represent our views as of the date of this press release and involve a number of judgments, risks and uncertainties. We anticipate that subsequent events and developments will cause our views to change. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ in our drug or supplement offerings include general market conditions, whether clinical trials demonstrate the efficacy and safety of our drug candidates to the satisfaction of regulatory authorities, or do not otherwise produce positive results which may cause us to incur additional costs or experience delays in completing, or ultimately be unable to complete the development and commercialization of our drug candidates; the clinical results for our drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials and marketing approval; our ability to achieve commercial success for our drug or supplement candidates, if approved; our limited operating history and our ability to obtain additional funding for operations and to complete the development and commercialization of our product candidates, and other risks and uncertainties set forth in “Risk Factors” in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to rely unduly upon these statements. All information in this press release is as of the date of this press release. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

    SOURCE: Aspire Biopharma Holdings, Inc.

    View the original press release on ACCESS Newswire

  • Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

    Breakthrough manufacturing process comes in preparation for upcoming commercial launch in Europe planned for later this year

    Proprietary process is already patented in several countries and is pending in the U.S.

    HERZLIYA, IL / ACCESS Newswire / March 17, 2026 / Regentis Biomaterials Ltd. (“Regentis” or the “Company”) (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced it has developed a new manufacturing process for its lead product, GelrinC®, an off-the-shelf hydrogel synchronized erosion and resorbable implant for the treatment of painful injuries to focal articular knee cartilage. The proprietary new process does not require the use of organic solvents which are not only flammable and toxic but also take up a major portion of the manufacturing process volume. This new solvent-free process more than quadruples production yield per batch.

    “In preparation for GelrinC’s commercial launch in Europe, planned for later this year, we have been developing and patenting proprietary improvements to our GelrinC manufacturing process that will improve production economics and corresponding gross margins,” said Dr. Ehud Geller, CEO and Executive Chairman of Regentis.

    Regentis has filed patents worldwide for its solvent-free GelrinC manufacturing process that have already been granted in India, China and Israel, and is pending in the US.

    GelrinC has CE Mark approval in the European Union and Regentis is conducting a pivotal U.S. Food and Drug Administration study which has completed over 50% enrollment.

    About GelrinC®

    Regentis’ lead product, GelrinC®, is a cell-free, off-the-shelf hydrogel synchronized erosion and resorbable implant for the treatment of painful injuries to focal articular knee cartilage. As an innovative regenerative medical product, GelrinC® offers an unprecedented solution that gives surgeons and payers an off-the-shelf, ready to use, simple to perform, reliable, and cost-effective procedure that provides patients with a single, 10-minute procedure, faster recovery, sustained pain relief, and functional improvement for more than 5 years, based on clinical study results to date. No effective off-the-shelf, ready to use treatment for focal knee cartilage defects is currently available on the market. GelrinC® has CE Mark approval in the European Union and is now being evaluated in a pivotal U.S. Food and Drug Administration (FDA) study, which has completed over 50% enrollment.

    About Regentis Biomaterials

    Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on orthopedic treatments, Regentis’ Gelrin platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone. Regentis’ lead product GelrinC®, is a cell-free, off-the-shelf hydrogel that is eroded and resorbed in the knee, allowing the surrounding cells to regenerate the cartilage in a controlled and synchronous process. GelrinC® aims to address a market of approximately 470,000 cases for cartilage knee repair annually in the U.S. where no off-the-shelf treatment is available.

    Forward Looking Statements

    This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words, and include beliefs regarding Regentis’ advancement towards commercialization and its cash runway. Forward-looking statements are based on Regentis’ current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: the ability of our clinical trials to demonstrate safety and efficacy of GelrinC or any future product candidate, and other positive results; the timing and focus of our preclinical studies and clinical trials, and the reporting of data from those studies and trials; the size of the market opportunity for of GelrinC or any future product candidate, including our estimates of the number of patients who suffer from the diseases we are targeting; our ability to accurately identify demand for product candidates; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of our product candidates; our ability to obtain FDA approval for of GelrinC or any future product candidate and obtain and maintain regulatory approval; our ability to obtain market acceptance of of GelrinC or any future product candidate from the medical community and third-party payors; our plans relating to the further development of GelrinC or any future product candidate, including additional disease states or indications we may pursue; existing regulations and regulatory developments in the United States and other jurisdictions; our plans and ability to obtain or protect intellectual property rights, including extensions of patent terms where available and our ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and our ability to attract and retain such personnel; our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; our dependence on third parties; our financial performance and our ability to repay our loans and debts; and our ability to negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and perform our obligations under such collaborations. For a more detailed description of the risks and uncertainties affecting Regentis, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the section titled “Risk Factors” in our Annual Report on Form 20-F filed with the SEC on February 24, 2026 and other public reports filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Regentis undertakes no duty to update such information except as required under applicable law.

    Contact:

    acarlquist@medicavp.com

    SOURCE: Regentis Biomaterials Ltd

    View the original press release on ACCESS Newswire